Literature DB >> 235665

Effect of diphosphonate on crystallization of calcium oxalate in vitro.

C Y Pak, M Ohata, K Holt.   

Abstract

Reliable techniques for the calculation of activity product (state of saturation), formation product (limit of metastability) and crystal growth of calcium oxalate were devised. The activity product at saturation was 2.53 times 10 minus 9 M2, and was independent of duration of incubation, solid-to-solution ratio, pH, calcium concentration or ionic strength. These tehcniques were utilized to assess the effect of disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP) on crystallization of calcium oxalate in an aqueous salt solution in vitro. EHDP increased the formation product of calcium oxalate, indicating an inhibition of nucleation of calcium oxalate. Further, it inhibited the crystal growth of calcium oxalate.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 235665     DOI: 10.1038/ki.1975.23

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  16 in total

1.  The inhibition of calcium oxalate crystal growth by multidentate organic phosphonates.

Authors:  J L Meyer; K E Lee; J H Bergert
Journal:  Calcif Tissue Res       Date:  1977-05-31

2.  Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth.

Authors:  Dawn Webber; Allen L Rodgers; Edward D Sturrock
Journal:  Urol Res       Date:  2007-11-07

Review 3.  Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.

Authors:  William G Robertson
Journal:  Urolithiasis       Date:  2016-11-29       Impact factor: 3.436

4.  Potential thermodynamic and kinetic roles of phytate as an inhibitor of kidney stone formation: theoretical modelling and crystallization experiments.

Authors:  Saajidah Fakier; Allen Rodgers; Graham Jackson
Journal:  Urolithiasis       Date:  2019-02-14       Impact factor: 3.436

5.  Interactions between calcium oxalate monohydrate crystals and Madin-Darby canine kidney cells: endocytosis and cell proliferation.

Authors:  Y Kohjimoto; S Ebisuno; M Tamura; T Ohkawa
Journal:  Urol Res       Date:  1996

Review 6.  Quantitation of response to therapy in calcium urolithiasis.

Authors:  J E Zerwekh; O Lawoyin; C Y Pak
Journal:  Urol Res       Date:  1979-09

7.  Assessment of Urinary Inhibitor or Promoter Activity in Uric Acid Nephrolithiasis.

Authors:  Steeve Doizi; Kathy Rodgers; John Poindexter; Khashayar Sakhaee; Naim M Maalouf
Journal:  J Urol       Date:  2015-12-23       Impact factor: 7.450

8.  Inhibition of calcium oxalate monohydrate (COM) crystal growth by pyrophosphate, citrate and rat urine.

Authors:  H Sidhu; R Gupta; S K Thind; R Nath
Journal:  Urol Res       Date:  1986

9.  Inhibition of calcium oxalate crystallization by commercial human serum albumin and human urinary albumin isolated from two different race groups: evidence for possible molecular differences.

Authors:  Allen L Rodgers; Priscilla D Mensah; Sylva L Schwager; Edward D Sturrock
Journal:  Urol Res       Date:  2006-12

10.  Morphological and immunological characteristics of nanobacteria from human renal stones of a north Indian population.

Authors:  Madhu Khullar; S K Sharma; S K Singh; Pratibha Bajwa; Farooq A Shiekh; Farooq A Sheikh; Vandana Relan; Meera Sharma
Journal:  Urol Res       Date:  2004-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.